Virpax Pharmaceuticals Inc (VRPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,067 | -8,677 | -6,671 | -3,220 | -15,190 |
| Accounts payable and accrued liabilities | 775 | 662 | 886 | -304 | 599 |
| Other Working Capital | -4,780 | -5,293 | -2,848 | -4,582 | 4,791 |
| Other Operating Activity | -641 | -534 | -740 | 377 | -55 |
| Operating Cash Flow | $-16,713 | $-13,842 | $-9,373 | $-7,729 | $-9,854 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 503 | 503 | 503 | N/A |
| Debt Repayment | N/A | -349 | -197 | -49 | N/A |
| Common Stock Issued | 9,084 | 5,017 | 2,250 | N/A | N/A |
| Other Financing Activity | 0 | -453 | -453 | 0 | 0 |
| Financing Cash Flow | $9,084 | $4,718 | $2,102 | $454 | $N/A |
| Beginning Cash Position | 9,142 | 9,142 | 9,142 | 9,142 | 18,995 |
| End Cash Position | 1,513 | 17 | 1,871 | 1,866 | 9,142 |
| Net Cash Flow | $-7,629 | $-9,124 | $-7,271 | $-7,275 | $-9,854 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,713 | -13,842 | -9,373 | -7,729 | -9,854 |
| Free Cash Flow | -16,713 | -13,842 | -9,373 | -7,729 | -9,854 |